Chemoattractant-induced phagocyte activation is an important mechanism of host defense. In phagocytes, induced activation of the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase leads to robust production of reactive oxygen species (ROS), which is essential for the elimination of ingested bacteria and fungi. However, extracellular ROS production by phagocyte NADPH oxidase (Nox2) can be harmful to the tissue and is a major cause of vascular injury in acute inflammation. This competing renewal application aims to understand how chemoattractant-induced neutrophil superoxide generation is regulated at the molecular and cellular levels. Building on the systems we developed and preliminary results obtained in the current funding cycle, this continuation application will investigate chemoattractant receptor signaling, phosphatase regulation of ROS production, and assembly of the NADPH oxidase complex in 3 specific aims.
Aim 1 will extend our recent finding that PKC? plays a unique and non-overlapping role in chemoattractant-induced ROS production, and proceed to determine the underlying mechanisms. Experiments will be designed to use both cell line-based and knockout approaches to determine whether PKC? regulates signaling pathways that lead to NADPH oxidase activation.
Aim 2 is based on our recent characterization of a deletion mutant of p47phox that mediates potent activation of NADPH oxidase in reconstituted cells without a physical interaction with p67phox. Experiments are designed to characterize a potentially novel mechanism for 47phox-mediated conformational change in cytochrome b558, which facilitates assembly of the NADPH oxidase complex.
Aim 3 will investigate an important regulatory mechanism for oxidant signaling, which involves protein phosphatase in limiting neutrophil ROS production. We propose to examine the negative regulation of NADPH oxidase by MAP kinase phosphatase 5 (MKP5), which is expressed in neutrophils and other phagocytes. Using both in vivo and ex vivo approaches, we will investigate how MKP5 protects host from LPS-induced vascular injury through suppression of ROS production in a mouse model of vascular inflammation. Collectively, these studies are expected to provide novel insights into the activation and inactivation mechanisms of phagocyte NADPH oxidase, thereby facilitating therapeutic intervention of ROS-mediated tissue injury.

Public Health Relevance

Phagocytes (a class of white blood cells that engulf bacteria and fungi) produce large amounts of reactive oxygen species that are toxic to bacteria and to host tissues. A balanced act of phagocyte activation is important for the maintenance of host defense capability and for minimizing unwanted tissue injury. The proposed studies will investigate how these cells are regulated by intrinsic mechanisms that prevent over-production of reactive oxygen species during acute inflammation, and how the machinery for oxidant production is assembled and activated when phagocytes are stimulated. Information derived from these studies is expected to have health benefit by reducing inflammatory tissue injury and multi-organ failure.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
High Priority, Short Term Project Award (R56)
Project #
2R56AI033503-16
Application #
7917012
Study Section
Cellular and Molecular Immunology - A Study Section (CMIA)
Program Officer
Dong, Gang
Project Start
2009-09-12
Project End
2010-05-31
Budget Start
2009-09-12
Budget End
2010-05-31
Support Year
16
Fiscal Year
2009
Total Cost
$392,500
Indirect Cost
Name
University of Illinois at Chicago
Department
Pharmacology
Type
Schools of Medicine
DUNS #
098987217
City
Chicago
State
IL
Country
United States
Zip Code
60612
Vergelli, Claudia; Schepetkin, Igor A; Ciciani, Giovanna et al. (2017) Synthesis of Five- and Six-Membered N-Phenylacetamido Substituted Heterocycles as Formyl Peptide Receptor Agonists. Drug Dev Res 78:49-62
Vergelli, Claudia; Schepetkin, Igor A; Ciciani, Giovanna et al. (2016) 2-Arylacetamido-4-phenylamino-5-substituted pyridazinones as formyl peptide receptors agonists. Bioorg Med Chem :
Chen, Mingjie; Zhou, Huibing; Cheng, Ni et al. (2014) Serum amyloid A1 isoforms display different efficacy at Toll-like receptor 2 and formyl peptide receptor 2. Immunobiology 219:916-23
Schepetkin, Igor A; Kirpotina, Liliya N; Khlebnikov, Andrei I et al. (2014) Antagonism of human formyl peptide receptor 1 (FPR1) by chromones and related isoflavones. Biochem Pharmacol 92:627-41
Sun, Lei; Zhu, Ziyan; Cheng, Ni et al. (2014) Serum amyloid A induces interleukin-33 expression through an IRF7-dependent pathway. Eur J Immunol 44:2153-64
Qian, Feng; Deng, Jing; Gantner, Benjamin N et al. (2012) Map kinase phosphatase 5 protects against sepsis-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol 302:L866-74
Hoeppner, Crystal Zoe; Cheng, Ni; Ye, Richard D (2012) Identification of a nuclear localization sequence in ?-arrestin-1 and its functional implications. J Biol Chem 287:8932-43
Qian, Feng; Le Breton, Guy C; Chen, Jia et al. (2012) Role for the guanine nucleotide exchange factor phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchanger 1 in platelet secretion and aggregation. Arterioscler Thromb Vasc Biol 32:768-77
Liu, Xiaowen; Ma, Bo; Malik, Asrar B et al. (2012) Bidirectional regulation of neutrophil migration by mitogen-activated protein kinases. Nat Immunol 13:457-64
Marty, Caroline; Ye, Richard D (2010) Heterotrimeric G protein signaling outside the realm of seven transmembrane domain receptors. Mol Pharmacol 78:12-8

Showing the most recent 10 out of 14 publications